These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27004346)

  • 41. Utility of MELD scoring system for assessing the prognosis of acute fatty liver of pregnancy.
    Li P; Lin S; Li L; Cui J; Wang Q; Zhou S; Fan J
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():161-166. PubMed ID: 31288187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric acute liver failure: etiology, outcomes, and the role of serial pediatric end-stage liver disease scores.
    Rajanayagam J; Coman D; Cartwright D; Lewindon PJ
    Pediatr Transplant; 2013 Jun; 17(4):362-8. PubMed ID: 23586473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modified Model for End-Stage Liver Disease eXcluding INR (MELD-XI) Score Predicts Early Death After Pediatric Heart Transplantation.
    Grimm JC; Magruder JT; Do N; Spinner JA; Dungan SP; Kilic A; Patel N; Nelson KL; Jacobs ML; Cameron DE; Vricella LA
    Ann Thorac Surg; 2016 Feb; 101(2):730-5. PubMed ID: 26347119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
    Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
    J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
    El-Sherif O; Jiang ZG; Tapper EB; Huang KC; Zhong A; Osinusi A; Charlton M; Manns M; Afdhal NH; Mukamal K; McHutchison J; Brainard DM; Terrault N; Curry MP
    Gastroenterology; 2018 Jun; 154(8):2111-2121.e8. PubMed ID: 29535028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
    Khandoga A; Iskandarov E; Angele M; Gerbes A; Frey L; Ağayev B; Jauch KW; Werner J; Guba M
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):153-8. PubMed ID: 26545081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indicators and outcome of liver transplantation in acute liver decompensation after flares of hepatitis B.
    Lee WC; Chou HS; Wu TJ; Lee CS; Lee CF; Chan KM
    J Viral Hepat; 2011 Mar; 18(3):193-9. PubMed ID: 20367797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of Cardiac MetaIodobenzylguanidine Imaging to Improve Prognostic Power of the Model for End-Stage Liver Disease Scoring System in Patients With Mild-to-Moderate Chronic Heart Failure.
    Hakui H; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kondo T; Ishimi M; Sato Y; Seo M; Ozaki T; Ikeda I; Fukuhara E; Sakata Y; Fukunami M
    Am J Cardiol; 2016 Jun; 117(12):1947-52. PubMed ID: 27237625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].
    Jeong EM; Hwang SG; Park HH; Park JH; Kim HT; Oh SW; Kho KH; Hong SP; Park PW; Rim GS; Kim SH
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):98-106. PubMed ID: 12824749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
    Wagener G; Raffel B; Young AT; Minhaz M; Emond J
    Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction.
    Farr M; Mitchell J; Lippel M; Kato TS; Jin Z; Ippolito P; Dove L; Jorde UP; Takayama H; Emond J; Naka Y; Mancini D; Lefkowitch JH; Schulze PC
    J Heart Lung Transplant; 2015 Jul; 34(7):873-82. PubMed ID: 25851466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
    Bernardi M; Gitto S; Biselli M
    J Hepatol; 2011 Jun; 54(6):1297-306. PubMed ID: 21145851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.
    Lynn AM; Singh S; Congly SE; Khemani D; Johnson DH; Wiesner RH; Kamath PS; Andrews JC; Leise MD
    Liver Transpl; 2016 Jun; 22(6):723-31. PubMed ID: 26970243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment.
    Yu JW; Wang GQ; Zhao YH; Sun LJ; Wang SQ; Li SC
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):492-6. PubMed ID: 17897912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
    Li JY; Deng Q; Wang Y; Xu MY; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CLIF-SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis.
    Jeong JH; Park IS; Kim DH; Kim SC; Kang C; Lee SH; Kim TY; Lee SB
    Medicine (Baltimore); 2016 Jun; 95(26):e3935. PubMed ID: 27367990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
    Luca A; Miraglia R; Maruzzelli L; D'Amico M; Tuzzolino F
    Radiology; 2016 Aug; 280(2):622-9. PubMed ID: 26982564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.